Is it okay to suddenly stop taking Trelagliptin after taking it for seven days?

Trelagliptin (Trelagliptin) is called a "weekly hypoglycemic drug" because of its unique long-acting properties. It can usually be taken once a week to maintain stable blood sugar. Its mechanism of action is to prolong the activity of GLP-1 by continuously inhibiting the DPP-4 enzyme, thereby helping the body regulate blood sugar. The effect of the drug lasts for about 7 days, so even if a diabetic patient temporarily stops taking the drug, the short-term blood sugar fluctuation may not be obvious. However, from the perspective of clinical and metabolic stability, sudden discontinuation of the drug after taking it for seven days is not recommended, because trolagliptin needs to be taken continuously to maintain long-term blood sugar balance.

If the patient interrupts the medication after one week of taking it, the inhibitory effect of DPP-4 in the body will gradually weaken, and the level of GLP-1 will decrease, resulting in decreased insulin secretion and increased glucagon secretion, leading to the risk of elevated blood sugar. Especially for patients whose blood sugar control is already unstable or whose pancreatic islet function is reduced, postprandial blood sugar rebound or even excessive blood sugar fluctuation may occur within 1 to 2 weeks after stopping the drug.

In addition, trotagliptin is a maintenance treatment drug. Short-term use can only provide temporary improvement in blood sugar and cannot achieve the true goal of glucose metabolism balance. Sudden discontinuation of medication may also trigger a "metabolic rebound" phenomenon, making it take longer for patients to return to a stable state after resuming medication. If the patient needs to discontinue medication due to special circumstances (such as surgery, infection, drug interaction, etc.), this should be done under the guidance of a doctor, and blood sugar should be balanced through diet control or temporary replacement drugs.

Trelagliptin itself has a long half-life, so it is not recommended to adjust the dosage interval or change the course of treatment on your own. For most patients with type 2 diabetes, maintaining a regular and continuous medication rhythm is the key to ensuring blood sugar stability and delaying the risk of complications. Stopping the drug after taking it for only seven days will not only disrupt the continuity of treatment, but may also affect future efficacy evaluations.

Reference materials:https://en.wikipedia.org/wiki/Trelagliptin